期刊文献+

胃癌端粒酶活性及ras基因突变的研究 被引量:4

The telomerase activity and mutation of ras gene in human gastric carcinoma
下载PDF
导出
摘要 目的 检测胃癌及癌前病变组织、胃炎组织端粒酶活性及ras基因变异,了解胃癌发生的生物学特性。方法 应用TRAP法对32例胃癌、16例异形增生、13例肠上皮化生、8例萎缩性胃炎、12例浅表性胃炎进行端粒酶活性及ras基因变异的测定。结果 胃癌组织28例(87.5%)端粒酶表达阳性,ras基因变异27例(84.4%)阳性;异形增生阳性分别为4例(25.0%)和5例(31.3%);肠上皮化生阳性分别为4例(30.8%)和4例(30.8%);萎缩性胃炎阳性分别为1例(8.4%)和2例(16.7%);胃炎组织阳性分别为0和1例(8.3%)。端粒酶及ras基因阳性表达与胃癌的部位、分化度、是否有淋巴转移无关。端粒酶活化与ras基因密切相关。结论 端粒酶活化及ras基因变异均与胃癌发生有关,可为胃癌的诊断提供可靠的指标。 Objective To evaluate the role of telomerase activity and mutation of ras gene in human gastric carcinoma.Method Using PCR-based telomeric repeat amplification protocol telomerase activity and mutation of ras gene was examined in 32 specimens of gastric carcinoma and 16 specimens of heterogenic hyperplasia, 13 specimens of intestinal metaplasia , 8 specimens of atrophic gastritis. Results It was found that the telomerase activity was positive in 28 (87.5 % ) and ras gene was positive in 27 of the 32 human gastric carcinoma specimens (84.4%) .The telomerase activity was positive in 4(25.0%) and ras gene was positive in 5 of the 16 (31.3%) specimens of heterogenic hyperplasia, telomerase activity was positive in 4(30.8%) and ras gene was also positive in 4 of the 13 specimens (30.8%) of intestinal metaplasia, telomerase activity was positive in 1(8.4%) and ras gene was positive in 2 of the 8 specimens (16.7% ) of atrophic gastritis , and telomerase activity was positive in 0 and ras gene was positive in 1 of the 12 specimens (8.3%) of superficial gastritis.The telomerase activity correlated with mutation of ras gene ( P < 0.05) . Conclusion The telomerase activity and mutation of ras gene may play an important role in development and progression of gastric carcinoma and might be a diagnostic marker of human gastric carcinoma.
出处 《中国肿瘤临床与康复》 2003年第4期319-321,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 胃癌 端粒酶活性 RAS基因 基因突变 癌前病变组织 肿瘤生物学 Stomach neoplasms Ras gene Telomerase
  • 相关文献

参考文献5

二级参考文献10

共引文献53

同被引文献25

  • 1朱玉琨,瞿良,袁荣国,张悦,李雪梅.大肠癌患者血清CA242、CA19蛳9和CEA水平测定的临床意义[J].肿瘤研究与临床,2004,16(4):227-229. 被引量:19
  • 2Tanaka K, Kurebayashi J, Sonoo H, et al. Expression of vascular endothelial growth factor family messenger RNA in diseased thyroid tissues[J]. Surg Today, 2002, 32 (9) :761-768.
  • 3Kakeji Y, Machara Y, Koga T, et al. Gastric cancer with high telome rase activity shows rapid development and invasiveness[J]. Oncol Rep, 2001, 8 (1):107-110.
  • 4Trarbach ML, Schleucher N, Weber D, et al. Phase Ⅰ study of the humanized anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in patients (pts) with advanced esophago-gastric (EG) adenocarcinoma (Abstr) [ J ].Proe Am Soe Clin Oncol, 2005,24: 3156.
  • 5Vernese ML, O Dwyer PJ. Monoclonal antibodies in the treatment of colorectal cancer [ J ]. Eur J Cancer, 2004,40 ( 9 ) :1292-301.
  • 6Holt CL, Stauffer C, Wallin JM, et al. Practical applications of genotypic surveys for forensic STR testing[ J]. Forensic Sci Int,2000,112: 91-109.
  • 7Kyo S, Inoue M. How to inhibit telomerase activity for cancer therapy [J]. Curr Med Chem Anti Cancer Agents, 2002,2 (5) :613-626.
  • 8Kakeji Y,Machara Y,Koga T,et al.Gastric cancer with high telomerase activity shows rapig development and invasiveness.Oncol Rep,2001,8(1):107
  • 9Shay JW,Bacchetti S.A survey of telomerase activity in human cancer.Eur J Cancer,1997,33:787
  • 10Hiyama K,Hirai Y,Kyoizumi S,et al.Activation of telomerase in hunan lymphocytes and hematopoietic progenitor cell.J Immunol.1995,155:371

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部